Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Parke

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Effective Drug Supply for Adaptive Clinical Trials: Recommendations by the DIA Adaptive Design Scientific Working Group Drug Supply SubteamNancy Burnham, Judith Quinlan, Weili He, et al.
BMC Medical Research Methodology|January 17, 2025
Why and how should we simulate platform trials? Learnings from EU-PEARLElias Laurin Meyer, Tobias Mielke, Marta Bofill Roig, et al.
Statistics in Medicine|March 16, 2026
Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation PrinciplesKim May Lee, Babak Choodari-Oskooei, Michael J Grayling, et al.
Journal of Biopharmaceutical Statistics|November 21, 2007
Innovative approaches for designing and analyzing adaptive dose-ranging trialsBjörn Bornkamp, Frank Bretz, Alex Dmitrienko, et al.
Clinical Pharmacology and Therapeutics|March 26, 2024
Regulatory Issues of Platform Trials: Learnings from EU-PEARLQuynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, et al.
Neuro-Oncology Practice|July 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseasesBritt A E Dhaenens, Günter Heimann, Annette Bakker, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Effective Drug Supply for Adaptive Clinical Trials: Recommendations by the DIA Adaptive Design Scientific Working Group Drug Supply SubteamNancy Burnham, Judith Quinlan, Weili He, et al.
BMC Medical Research Methodology|January 17, 2025
Why and how should we simulate platform trials? Learnings from EU-PEARLElias Laurin Meyer, Tobias Mielke, Marta Bofill Roig, et al.
Statistics in Medicine|March 16, 2026
Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation PrinciplesKim May Lee, Babak Choodari-Oskooei, Michael J Grayling, et al.
Journal of Biopharmaceutical Statistics|November 21, 2007
Innovative approaches for designing and analyzing adaptive dose-ranging trialsBjörn Bornkamp, Frank Bretz, Alex Dmitrienko, et al.
Clinical Pharmacology and Therapeutics|March 26, 2024
Regulatory Issues of Platform Trials: Learnings from EU-PEARLQuynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, et al.
Neuro-Oncology Practice|July 15, 2024
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseasesBritt A E Dhaenens, Günter Heimann, Annette Bakker, et al.
Pageof 2